Never Split the Science: Mark Boulding, Master Negotiator and Rare Disease Pioneer

In this episode of GenCast, Mark Boulding—Executive Vice President and Chief Legal Officer at PTC Therapeutics—shares the secrets of how he went from law firm partner to the leadership team of a $4B public biotech company. 

Dive deep into strategic negotiations with real-world applications inspired by Chris Voss’ tactics from Never Split the Difference, drawn from Mark's experiences negotiating deals with big pharma. Learn how Mark’s unique approaches to the interpersonal aspects of business negotiations—when to take bold risks and how to manage information flows—have helped shape PTC’s pioneering journey in developing life-saving therapies for individuals living with rare diseases with significant funding from business development deals over more than two decades.

Discover how to use anchoring in non-quantitative contexts, deploy creative dispute resolution techniques like baseball arbitration, and create win-win scenarios using tactical empathy. Get an inside look at how Mark turned challenging situations into groundbreaking successful deals, making biotech negotiations not just a science, but an art form